US 11117970
Human antibodies to PD-L1
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 11117970 (Human antibodies to PD-L1) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 15
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K39/3955, A61K39/39558